BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 21, 1997
View Archived Issues
First report of kappa-opioid agonist efficacy in humans
Read More
Spotlight on new drugs for cancer
Read More
Selective RAR-gamma ligands described by Roche
Read More
SmithKline Beecham discloses selective, nonpeptide NK3 antagonists
Read More
NK3/NK2 receptor antagonists from SmithKline Beecham
Read More
ICN describes antisense oligonucleotides for IL-8 and/or IL-8R
Read More
Biota reports new agents for influenza
Read More
Novel inhibitors of geranylgeranylation from Baldacci
Read More
DuPont Merck prepares anticoagulant aminoboronic acids
Read More
GeneMedicine receives quarterly payment from Corange in anticancer gene medicine collaboration
Read More
New treatment in development for Pompe's disease
Read More
Low-dose diuretic prevents heart failure in the elderly
Read More
Medeva acquires license to anthracycline derivative for the treatment of bladder cancer
Read More
AmBisome recommended for approval by FDA advisory committee
Read More
ProLease drug formulation for the treatment of hormone-mediated disorders enters clinical trials
Read More
Lung cancer survival improved with new radiotherapy technique
Read More
Helicon Therapeutics: new company focuses on memory disorders and other CNS diseases
Read More
GHRH antagonist active in vivo against human renal adenoarcinoma
Read More
Genzyme Molecular Oncology and NCI enter drug discovery collaboration
Read More
SRI licenses drug formulation technology to Dura
Read More
Meridian launches TruJect autoinjector
Read More
VA-045 ameliorates head injury-induced neurological dysfunction
Read More
Rogaine Extra Strength for Men recommended for approval as OTC
Read More
Antiallergic and bronchodilating effects of KF-19514 in guinea pigs
Read More
CoCensys to copromote Zarontin for pediatric epilepsy
Read More
Syncor to distribute two radiopharmaceuticals from DuPont Merck
Read More
TAP receives FDA approval to market new formulation of Lupron Depot
Read More
